Rob Dillard

DocwireNews

The results of a new study suggest that the use of spinal cord stimulators (SCSs) do not reduce opioid use or nonpharmacologic pain interventions compared with conventional medical management (CMM). The results appeared in JAMA Neurology.&nbsp;In this retrospective study, researchers assessed a population of 7,560 patients (average age, 63.5, 40.7% male, 59.3%) mean (SD) age was 63.5 (12.5) years, 3080 (40.7%)&nbsp; male, and 4480 (59.3%) female with incident diagnosis codes for failed back surgery syndrome, complex regional pain syndrome, chronic pain syndrome, and other chronic postsurgical back and extremity pain.The researchers measured primary chronic pain treatment modalities, including pharmacologic and nonpharmacologic pain interventions, and total costs. Analysis took place from February 2021 to August 2022.According to the results, patients treated with SCSs had higher odds of chronic opioid use compared with patients treated with CMM&nbsp; During months 13 to 24, there was no significant difference in chronic opioid use (adjusted odds ratio [aOR], 1.14; 95% CI, 1.01-1.29). Also, almost 18% of patients treated with SCS experienced SCS-related complications within 2 years, and 22.1% had device revisions and/or removals. Overall, total costs of care in the first year were $39,000 higher with SCS than CMM, the researchers noted.&ldquo;SCS placement was not associated with a reduction in opioid use or nonpharmacologic pain interventions at 2 years. SCS was associated with higher costs, and SCS-related complications were common,&rdquo; the researchers concluded.&nbsp;

Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Sara Nunnery, MD, MSCI

Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?

HER2 Breast Cancer

Latest News

Spinal Cord Stimulators Do Not Reduce Opioid Use in Chronic Pain Patients

Neurology

The results of a new study suggest that the use of spinal cord stimulators (SCSs) do not reduce opioid use or nonpharmacologic pain interventions compared with conventional ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe